NasdaqGS:BIIB
NasdaqGS:BIIBBiotechs

Biogen (NasdaqGS:BIIB) Partners With City Therapeutics in US$1 Billion RNAi Therapy Deal

Biogen (NasdaqGS:BIIB) recently announced a collaboration with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases, contributing to a 6% share price increase over the past month. While this move aligns with an uptick in the broader tech sector due to policy shifts, other market responses could have influenced this rise. The announcement coincided with positive market momentum, as evident from major indexes inching upwards during this period, reflecting...
NYSE:CRBG
NYSE:CRBGDiversified Financial

Corebridge Financial (NYSE:CRBG) Proposes Board Authorization Amendment to Company Bylaws

Corebridge Financial (NYSE:CRBG) has recently proposed an amendment to its bylaws to give the board greater flexibility in managing amendments, with a special stockholder meeting set for July. Over the past month, Corebridge's shares rose by 8%, which contrasts with the broader market's 3% decline. This could be attributed to a combination of the company's share repurchases and dividend announcements during the period. While Corebridge's Q1 earnings showed losses, these governance changes may...
NasdaqCM:ATYR
NasdaqCM:ATYRBiotechs

High Growth Tech Stocks in the US to Watch This May 2025

The U.S. stock market has experienced significant volatility recently, with major indices like the Dow Jones and Nasdaq Composite seeing sharp gains following a tech sector rally driven by shifts in trade policy under the Trump administration. In this dynamic environment, high-growth tech stocks can be particularly appealing to investors seeking opportunities that align with current market momentum and technological advancements.